[1]
2025. Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics. Pakistan Journal of Medical & Cardiological Review. 4, 4 (Dec. 2025), 1970–1987. DOI:https://doi.org/10.64105/d0gq9a09.